Corporate profile

Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. We classify our products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships

Our Radiopharmaceutical Oncology products help healthcare professionals Find, Fight and Follow cancer. 

Our leading Precision Diagnostic products assist healthcare professionals to Find and Follow diseases, with a focus in cardiology. 

Our Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma solutions platforms.

Our commercial products are used by nuclear medicine physicians, oncologists, radiologists, urologists, cardiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. 

Lantheus is headquartered in Massachusetts, with additional offices in New Jersey, Canada, Germany, Sweden, Switzerland and the United Kingdom.

$

Minimum 15 minutes delayed. Source: LSEG

Latest press releases

June 3, 2026

Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

June 2, 2026

Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year

May 27, 2026

Lantheus to Present at the William Blair 46th Annual Growth Stock Conference

Events

Jun 3, 2026 12:10 PM EDT

William Blair 46th Annual Growth Stock Conference

May 7, 2026 8:00 AM EDT

Q1 2026 Lantheus Earnings Conference Call

Mar 10, 2026 8:00 AM EDT

Leerink Global Healthcare Conference

See all

Supplemental financial information

May 07, 2026

Selected Historical Financial Results

May 07, 2026

1Q 2026 Reconciliation of GAAP to Non-GAAP Financial Measures

Feb 26, 2026

4Q 2025 Reconciliation of GAAP to Non-GAAP Financial Measures

See all